Amid current market volatility, PMI has decided to pause the sale of its $1 billion U.S. cigar business. Sales of ZYN nicotine pouches remained strong in Q1 2025, with smoke-free products like ZYN and IQOS accounting for 42% of total revenue. PMI’s Kentucky plant resumed ZYN production ahead of schedule, aiming for an annual capacity of 900 million cans, while a new facility in Colorado is expected to begin operations in early 2026.

A study by Massachusetts General Hospital found that the oral smoking cessation drug varenicline significantly improves e-cigarette quit rates among young people aged 16 to 25. In a 12-week trial, 50% of participants in the varenicline group successfully quit vaping, compared to just 14% in the placebo group. After six months, 28% of those in the treatment group remained vape-free.

In Q1 2025, Philip Morris International reported net revenue of $9.301 billion, up 5.8% year-over-year, with operating income rising 16.4% to $3.544 billion. Smoke-free products accounted for 42% of net revenue and 44% of gross profit. Total shipment volume grew 14.4%, with heated tobacco products like IQOS reaching record market shares in Japan and Europe. ZYN nicotine pouch shipments in the U.S. surged 53% year-over-year.

Percentage of tobacco and e-cigarette sales to minors drops to 11.8% in Wisconsin, U.S. Health officials call for focus on preventing early youth exposure to tobacco products.

Bulgarian customs seize nearly 6000 illegal e-cigarettes in Sofia, largest single bust discovered during nationwide crackdown.